SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine
Shots:
- SMA Foundation and PTC will provide an initial investment of up to $60M in research to discover & develop regenerative treatments in neuromuscular diseases
- The focus of the agreement is advance scientific research in SMA and other neuromuscular disorders to develop new treatments
- The availability of several disease-modifying therapies has made regenerative interventions the next frontier in drug discovery and development
Ref: PRNewswire | Image: Wikipedia
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com